인쇄하기
취소

Yuhan to go global with gastritis drug Revanex

Published: 2008-04-08 07:00:00
Updated: 2008-04-08 07:00:00
Yuhan Corporation has been most active with its homegrown gastric acid pump antagonist Revanex (revaprazan) in exploring a number of overseas markets, including 10 countries in South America.

Yuhan says it signed an exclusive licensing agreement with China's Shenzhen Zhijun Pharmaceutical Co., an affiliated company of China National Pharmaceutical Group, for Revanex on March 31.

The signi...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.